Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Children's Mercy's TaGSCAN; COSMIC

Premium

Children's Mercy Hospital has launched its Targeted Gene Sequencing and Custom Analysis, or TaGSCAN, test to diagnose pediatric genetic diseases. The test screens for more than 750 diseases that are the result of a single-gene defect, such as muscular dystrophy, cystic fibrosis, polycystic kidney disease, and hundreds of others. The test costs less than $3,200 and has a turnaround time of six to eight weeks. It is available to Children's Mercy patients and referring physicians through the Center for Pediatric Genomic Medicine at Children's Mercy.


The Wellcome Trust Sanger Institute has released version 67 of COSMIC, the Catalog of Somatic Mutations in Cancer. The latest release now includes copy number aberrations as well as somatic mutations. It also includes three new curated genes, 11 new fusion gene pairs, 20 new systematic screen publications, and six new census genes.

COSMIC's Cancer Cell Line Project also now contains the full exome sequencing of 1,015 cell lines. COSMIC now contains a total of 7,954 whole-genome sequencing samples.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.